1. Home
  2. QNTM vs CURB Comparison

QNTM vs CURB Comparison

Compare QNTM & CURB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QNTM
  • CURB
  • Stock Information
  • Founded
  • QNTM 1998
  • CURB 2024
  • Country
  • QNTM Canada
  • CURB United States
  • Employees
  • QNTM N/A
  • CURB N/A
  • Industry
  • QNTM
  • CURB
  • Sector
  • QNTM
  • CURB
  • Exchange
  • QNTM NYSE
  • CURB NYSE
  • Market Cap
  • QNTM 9.1M
  • CURB 2.5B
  • IPO Year
  • QNTM N/A
  • CURB N/A
  • Fundamental
  • Price
  • QNTM $4.08
  • CURB $23.43
  • Analyst Decision
  • QNTM
  • CURB Buy
  • Analyst Count
  • QNTM 0
  • CURB 5
  • Target Price
  • QNTM N/A
  • CURB $25.69
  • AVG Volume (30 Days)
  • QNTM 220.7K
  • CURB 745.0K
  • Earning Date
  • QNTM 01-14-2025
  • CURB 02-07-2025
  • Dividend Yield
  • QNTM N/A
  • CURB 1.07%
  • EPS Growth
  • QNTM N/A
  • CURB N/A
  • EPS
  • QNTM N/A
  • CURB 0.06
  • Revenue
  • QNTM N/A
  • CURB $111,428,000.00
  • Revenue This Year
  • QNTM N/A
  • CURB N/A
  • Revenue Next Year
  • QNTM N/A
  • CURB N/A
  • P/E Ratio
  • QNTM N/A
  • CURB $381.01
  • Revenue Growth
  • QNTM N/A
  • CURB 52.36
  • 52 Week Low
  • QNTM $2.70
  • CURB $18.80
  • 52 Week High
  • QNTM $70.85
  • CURB $25.35
  • Technical
  • Relative Strength Index (RSI)
  • QNTM 49.93
  • CURB N/A
  • Support Level
  • QNTM $3.50
  • CURB N/A
  • Resistance Level
  • QNTM $4.67
  • CURB N/A
  • Average True Range (ATR)
  • QNTM 0.69
  • CURB 0.00
  • MACD
  • QNTM 0.07
  • CURB 0.00
  • Stochastic Oscillator
  • QNTM 46.00
  • CURB 0.00

About QNTM QUANTUM BIOPHARMA LTD

Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.

About CURB CURBLINE PPTYS CORP

Curbline Properties Corp is a publicly-traded REIT operating Convenience retail properties, offering enhanced access and visibility relative to other retail property types. The properties generally consist of a ubiquitous row of shop units along with dedicated parking leased to a diversified mixture of national and local service and restaurant tenants that cater to daily convenience trips from the growing suburban population.

Share on Social Networks: